Skip to main navigation

About Us
Technology
Pipeline
Patients
Clinical Trials
Collaborations
Investors + Media
Careers

About Us
Technology
Pipeline
Patients
Clinical Trials
Collaborations
Investors + Media
Careers

News Releases

Investors + Media
Stock Information
News Releases
Events + Presentations
Financials + SEC Filings
Corporate Governance

News Releases

Year

Jan 06, 2021

Sangamo Therapeutics Announces Departure of Chief Financial Officer Sung Lee

BRISBANE, Calif. --(BUSINESS WIRE)--Jan. 6, 2021-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that Chief Financial Officer Sung Lee is leaving the Company to pursue a new opportunity overseas. Mr. Lee’s last day of employment will be February 1, 2021 .

Additional Formats

PDF Version

Jan 05, 2021

Sangamo Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference

BRISBANE, Calif. --(BUSINESS WIRE)--Jan. 5, 2021-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present a corporate overview at the 39 th Annual J.P. Morgan Healthcare Conference on Wednesday, January 13 th at 5:20pm EST .

Additional Formats

PDF Version

© Sangamo Therapeutics

Disclaimer
Privacy Policy